{"id": "1386982704239964163", "creation": 1619517420.0, "user_id": "29486496", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "#China's CNBG (Sinopharm) has obtained approval for human trials for its third #COVID19 #vaccine candidate, a gene recombinant vaccine. Unlike inactivated vaccines, high-grade biosafety labs are not required to manufacture this new vaccine. https://t.co/pEyYKrPusC", "first_save": 1634559108.199414, "hashtags": ["#CHINA", "#COVID19", "#VACCINE"]}